Literature DB >> 1385751

Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.

M R Zarrindast1, A Jamshidzadeh.   

Abstract

1. Bromocriptine (2, 4 and 8 mg kg-1, i.p.), physostigmine (0.05, 0.1 and 0.2 mg kg-1, i.p.) and pilocarpine (1, 3 and 5 mg kg-1, i.p.) induced dose-dependent yawning in rats. 2. These responses were reduced in a dose-dependent manner by pretreatment with morphine. 3. The inhibitory effect of morphine was reversed by naloxone. 4. Naloxone alone induced slight but significant yawning. 5. The present results suggest that morphine inhibits yawning in rats at an opiate receptor downstream from the sites at which cholinoceptor and dopamine D2 activation induce yawning. The anatomical location of these sites remains to be established.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385751      PMCID: PMC1908467          DOI: 10.1111/j.1476-5381.1992.tb09037.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

Review 1.  Localization of transmitter candidates in the brain: the hippocampal formation as a model.

Authors:  J Storm-Mathisen
Journal:  Prog Neurobiol       Date:  1977       Impact factor: 11.685

2.  Yawning.

Authors:  J BARBIZET
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-08       Impact factor: 10.154

3.  Evidence for dopamine receptors mediating sedation in the mouse brain.

Authors:  G Di Chiara; M L Porceddu; L Vargiu; A Argiolas; G L Gessa
Journal:  Nature       Date:  1976-12-09       Impact factor: 49.962

4.  Opiate actions on mesocortical dopamine metabolism in the rat.

Authors:  H S Kim; S Iyengar; P L Wood
Journal:  Life Sci       Date:  1986-11-24       Impact factor: 5.037

5.  Acute effects of morphine on dopamine synthesis and release and tyrosine metabolism in the rat striatum.

Authors:  C Gauchy; Y Agid; J Glowinski; A Cheramy
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

6.  Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.

Authors:  P G Guyenet; A F Javory; J C Beaujouan; B J Rossier; J Glowinski
Journal:  Brain Res       Date:  1975-02-07       Impact factor: 3.252

7.  Comparative effects of opiate agonists methadone, levorphanol, and their isomers on the release of cortical ACh in vivo and in vitro.

Authors:  K Jhamandas; V Hron; M Sutak
Journal:  Can J Physiol Pharmacol       Date:  1975-08       Impact factor: 2.273

8.  Effects of delta and mu opiopeptides on the turnover and release of dopamine in rat striatum.

Authors:  N Yonehara; D H Clouet
Journal:  J Pharmacol Exp Ther       Date:  1984-10       Impact factor: 4.030

9.  Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats.

Authors:  K Yamada; M Tanaka; K Shibata; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

View more
  6 in total

1.  Effects of GABAergic drugs on physostigmine-induced yawning in rats.

Authors:  M R Zarrindast; V Toloui; B Hashemi
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

2.  Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.

Authors:  Gregory T Collins; Jeffrey M Witkin; Amy H Newman; Kjell A Svensson; Peter Grundt; Jianjing Cao; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2005-04-15       Impact factor: 4.030

3.  Drug-induced yawning: a review of the French pharmacovigilance database.

Authors:  Agnès Sommet; Maryline Desplas; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice.

Authors:  Gregory T Collins; Andrew Truccone; Faiza Haji-Abdi; Amy Hauck Newman; Peter Grundt; Kenner C Rice; Stephen M Husbands; Benjamin M Greedy; Cecile Enguehard-Gueiffier; Alain Gueiffier; Jianyong Chen; Shaomeng Wang; Jonathan L Katz; David K Grandy; Roger K Sunahara; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2009-01-09       Impact factor: 4.030

5.  Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats.

Authors:  M Poncelet; J Souilhac; C Gueudet; J P Terranova; D Gully; G Le Fur; P Soubrié
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

6.  Turmeric active substance, curcumin, enhanced apomorphine-induced yawning in rats.

Authors:  Esmaeal Tamaddonfard
Journal:  Avicenna J Phytomed       Date:  2013
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.